A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of unknown primary
medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …
AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.
- ctDNA and AI for treatment monitoring and early detection (3)
- Liquid biopsies and extracellular vesicles for early cancer detection (4)
- Methylation-based ML to identify cancers' tissue of origin (3)
- All Other Stories
ctDNA and AI for treatment monitoring and early detection
Liquid biopsies and extracellular vesicles for early cancer detection
Methylation-based ML to identify cancers' tissue of origin
All Other Stories
Related Stories
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 6 wks
AI face photos may predict cancer survival years earlier / 2 months
National study to use genetic testing to guide cancer survivor follow-up / 2 months
Some tumors kill neighboring healthy cells to fuel growth / 4 wks
MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 7 wks
ctDNA blood test pinpoints who needs chemo after colorectal liver surgery / 4 days
CAR‑T depletes mutant calreticulin cells, offering myelofibrosis hope / 6 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Clinical Trials, Alzheimer's disease, Medical Devices, Price Transparency and look for the RSS link.
StackHealth Time Machine